Aptus Pharma Ltd Q2 FY27 earnings call summary

Earnings call of 26 Oct 2026, summarised by AI from the filing.

Growth is led by prescription generation, with coverage to reach 46% of India by March 2027 from two states before listing.

Key takeaways

1. Distribution Growth is led by prescription generation, with coverage to reach 46% of India by March 2027 from two states before listing.

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

• Q2 FY27: Earnings call (26 Oct 2026), Results deck (23 Oct 2026)
• Q1 FY27: Results deck (21 Aug 2026)
• Q4 FY26: Results press release (28 Apr 2026)
• Other events: Strategy deck (7 Feb 2026)